- Professor, Global Health
- Professor, Pharmacy
- Adjunct Professor, Epidemiology
- Adjunct Professor, Health Metrics Sciences
- Adjunct Professor, Health Services
- Associate Dean, School of Pharmacy
Director, Global Medicines Program
Harris Hydraulics Building, Room 321
Seattle, WA 98105
Select from the following:
Dr. Stergachis’ research and teaching focuses on the safety and use of medicines and vaccines in LMICs. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries and has developed novel approaches for HIV pharmacovigilance and strengthening pharmacy services in LMICs. He is Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network, a member of Advisory Group to Global Alert and Response for the WHO, and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He is an elected member of the National Academy of Medicine. He directs the UW Collaborating Center on Mass Gatherings Public Health. Previously, he was senior advisor to the Bill & Melinda Gates Foundation Safety Surveillance Working Group, a member of the US FDA Drug Safety and Risk Management Advisory Committee, and Chair of the Malaria in Pregnancy Consortium Safety Working Group.
- PhD (University of Minnesota)
- MS (University of Minnesota)
- BPharm (Washington State University)
- Biodefense Infectious Diseases
- Burden of Disease
- Drug and Vaccine Development
- Education and Training
- Health Outcomes
- Health Technologies
- Infectious Diseases
- Infectious Diseases (other than STDs)
- Maternal Child Health (incl. Reproductive Health)
- Metrics and Evaluation
- Pharmaceutical Science
Hay SI, Rao PC, Dolecek C, Day NPJ, Stergachis A, Lopez AD, Murray CJL. Measuring and mapping the global burden of antimicrobial resistance. BMC Medicine. 2018 Jun 4;16:78.
Oneko M, Vala A, Ruperez M, Macete E, Menendez C, Nakanabo-Diallo S, Kazienga A, Valea I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, ter Kuile F; Stergachis A. First trimester artemisinin derivatives and quinine treatments and their association with adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLOS Medicine. May 2 2017;14(5):e1002290.
Babigumira J, Lubinga SJ, Jenny AM, Larsen-Cooper E, Crawford J, Matemba C, Stergachis A. Impact of pharmacy worker training and deployment on access to essential medicines for children under five in Malawi: a cluster quasi-experimental evaluation. BMC Health Services Research 2017. 17(1):638.
Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison LP, Stergachis A. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost Utility Analysis. Drug Saf. 2016 Sep;39(9):859-72.
Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Eng J Med 1996; 334:1362-6.